Antispasmodic Recommendations for Non-Specific Abdominal Pain
For adults with non-specific abdominal pain and no red-flag features, use hyoscine (hyoscyamine), dicyclomine, or peppermint oil as first-line antispasmodic therapy, as these are the only antispasmodics available in the United States with evidence supporting their use. 1
Available Antispasmodic Options in North America
The 2022 AGA guidelines make a conditional recommendation for antispasmodics in patients with IBS-related abdominal pain, though the evidence quality is low. 1 The key limitation for North American practice is availability—only three antispasmodics studied in clinical trials are accessible in the United States: hyoscine (also called hyoscyamine or hyoscine butylbromide), dicyclomine, and peppermint oil. 1
Mechanism and Efficacy
Antispasmodics work by:
- Reducing smooth muscle contraction in the GI tract
- Possibly reducing visceral hypersensitivity 1
Evidence from a Cochrane Review of 22 RCTs (2,983 patients) demonstrated that antispasmodics provided adequate global relief of symptoms (RR 0.67; 95% CI 0.55-0.80) and improvement in abdominal pain (RR 0.74; 95% CI 0.59-0.93) compared to placebo. 1 However, twelve different antispasmodics were studied with considerable variation in dosing schedules and endpoints, making individual drug comparisons difficult.
Specific Agent Considerations
Hyoscine (Hyoscine Butylbromide/Hyoscyamine)
- Anticholinergic agent with high affinity for muscarinic receptors on GI smooth muscle 2
- Bioavailability <1% after oral administration, but high tissue affinity keeps it active at the intestinal site 2
- Does not penetrate the blood-brain barrier, resulting in better tolerability 2
- Available as oral or rectal formulation 2
Dicyclomine
- Anticholinergic/antimuscarinic agent
- Inhibits GI smooth muscle contraction 3
Peppermint Oil
- Recent network meta-analysis (2026) showed small-intestinal release peppermint oil demonstrated strong anxiolytic effects alongside pain relief 4
- Works as a direct smooth muscle relaxant 3
Dosing Approach
While the guidelines note considerable variation in dosing schedules across studies 1, start with standard manufacturer-recommended doses and adjust based on response. The evidence does not support specific dosing protocols, as studies varied widely in their regimens.
Common Pitfalls and Safety
Common adverse events include dry mouth, dizziness, and blurred vision—all anticholinergic effects—but no serious adverse events were reported in the systematic reviews. 1
Critical caveat: Regular use of anticholinergic antispasmodics may be limited in patients with constipation due to their anticholinergic effects. 1 In such cases, peppermint oil may be preferable as it works through a different mechanism.
When Antispasmodics Are Insufficient
If first-line antispasmodics prove ineffective, consider switching to an antispasmodic with a different mode of action or adding acetaminophen/NSAIDs for more severe cases. 5 Recent evidence suggests fixed-dose combinations of antispasmodics with NSAIDs or two different antispasmodics can improve compliance and provide synergistic pain reduction. 5
For patients with significant psychological comorbidities or refractory symptoms, tricyclic antidepressants (particularly low-dose amitriptyline 10 mg at bedtime) have demonstrated efficacy for abdominal pain independent of effects on depression. 1
Evidence Quality Limitations
The overall certainty of evidence for antispasmodics remains low to very low due to risk of bias, publication bias, and imprecision across studies. 1 Most trials were small, used varying diagnostic criteria, and lacked standardized endpoints. Despite these limitations, the consistent direction of benefit across multiple trials and the favorable safety profile support their use as first-line therapy for non-specific abdominal pain without red flags.